These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10669656)

  • 1. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells.
    Bourcier T; Libby P
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):556-62. PubMed ID: 10669656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity.
    Swiatkowska M; Pawlowska Z; Szemraj J; Drzewoski J; Watala C; Cierniewski CS
    Jpn J Pharmacol; 2002 Dec; 90(4):337-44. PubMed ID: 12501010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
    Haslinger B; Kleemann R; Toet KH; Kooistra T
    Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
    Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.
    Haslinger B; Goedde MF; Toet KH; Kooistra T
    Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells.
    Ekhterae D; Stanley JC
    J Vasc Surg; 1995 Jun; 21(6):953-62. PubMed ID: 7776475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells.
    Kunieda Y; Nakagawa K; Nishimura H; Kato H; Ukimura N; Yano S; Kawano H; Kimura S; Nakagawa M; Tsuji H
    Thromb Res; 2003 Jun; 110(4):227-34. PubMed ID: 14512087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins.
    Essig M; Nguyen G; Prié D; Escoubet B; Sraer JD; Friedlander G
    Circ Res; 1998 Oct; 83(7):683-90. PubMed ID: 9758637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells.
    Gallicchio M; Argyriou S; Ianches G; Filonzi EL; Zoellner H; Hamilton JA; McGrath K; Wojta J
    Arterioscler Thromb; 1994 May; 14(5):815-23. PubMed ID: 8172858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W; Dulak J; Frick M; Alber HF; Schwarzacher SP; Ares MP; Nilsson J; Pachinger O; Weidinger F
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):58-63. PubMed ID: 12524225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells.
    Markle RA; Han J; Summers BD; Yokoyama T; Hajjar KA; Hajjar DP; Gotto AM; Nicholson AC
    J Cell Biochem; 2003 Sep; 90(1):23-32. PubMed ID: 12938153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
    Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
    Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
    van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
    Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells.
    Mukai Y; Wang CY; Rikitake Y; Liao JK
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1937-42. PubMed ID: 17172275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
    Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G
    Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
    Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
    Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells.
    Nogaki F; Muso E; Yashiro M; Kasuno K; Kamata T; Ono T; Sasayama S
    Kidney Int Suppl; 1999 Jul; 71():S198-201. PubMed ID: 10412775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.
    Llorente-Cortés V; Martínez-González J; Badimon L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):738-46. PubMed ID: 9598832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.